|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.0101 - 0.0147|
|52 Week Range||0.0100 - 0.0384|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Easton Pharmaceuticals Inc. (EAPH) announces that it has entered into an Agreement to acquire an interest in a Real Estate Development Project just outside of Toronto, with 3 year cumulative profits expected to exceed $30,000,000 CAN. As part of its plan to enter more lucrative market segments, Easton has signed an agreement with 2315446 Ontario Inc. to acquire an interest in a development property in Cobourg, Ontario, a growing lakefront community east of Toronto. The property is approximately 2.5 acres and is zoned for a multi-residential development to allow up to 48 units.
TORONTO, ON, June 25, 2018-- Easton Pharmaceuticals Inc. is pleased to announce the appointment of Mr. Panagis Alivizatos, to its Board of Directors to enhance existing businesses and moves towards new ...
As a result of recent developments and announcements with Easton’s JV partner, 1124123 Ontario Limited, operating as Alliance Group, where it announced that revenues have commenced on its Georgina property, located just north of Toronto, Ontario, Canada, Easton has made the decision to appoint Vince Demasi to Easton’s board of directors and management team. Mr. Demasi has accepted the position of Chief Operating Officer.
Easton Pharmaceuticals Inc. (OTC: EAPH) Announces that Easton and its JV partner 1124123 Ontario Limited (O/A - Alliance Group) generated $40,000 in in revenues in the first week of operations on its Georgina property. After the delivery of heavy machinery to the Georgina property, the company can disclose that operations have generated over $40,000 CDN in revenues in its first week of operations.
Easton’s JV partner, 1124123 Ontario Limited (o/a – Alliance Group) is pleased to announce that revenues have commenced on its Georgina property, located just north of Toronto, Ontario, Canada. The first business is soil, while the company is gearing up for operations to soon commence from its aggregate business and marijuana production. Easton Pharmaceuticals and Alliance Group will be providing many more detailed updates in the coming weeks on revenue generation and future projections which can now be booked on Easton’s financial statements.
Easton Pharmaceuticals, Inc. is pleased to announce its final payment which completes its $1.3 Million CDN JV agreement with Canadian based 1124123 Ontario Limited towards a 50% property ownership interest ...
Easton Pharmaceuticals, Inc. , is pleased to announce, pursuant to its previously announced closed agreement with Canadian based -- 1124123 Ontario Limited -- that its legal team has notified Easton / ...
Easton Pharmaceuticals Inc. and its JV partner BMV Medica SA de CV announces that its distributor Windsor Pharmaceuticals SA has received regulatory approval for two of its exclusively licensed Women's ...
Easton Pharmaceuticals, Inc. , is pleased to announce, pursuant to its previously announced Closing Agreement with Canadian based 124123 Ontario Inc. , Easton has advanced $1,000,000 cdn in payments to ...
Easton Pharmaceuticals, Inc. , is pleased to announce, pursuant to its previously announced Closing with Canadian based, joint venture partner, 1124123 Ontario Limited -- executes $6,000,000 CDN aggregate ...